UK markets open in 31 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,172.64 +409.61 (+2.31%) CRUDE OIL
79.61 +0.61 (+0.77%) GOLD FUTURES
2,325.90 +14.90 (+0.64%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,869.11 -1,701.45 (-3.58%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 369.30B |
| Enterprise value | 348.39B |
| Trailing P/E | 30.33 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 10.27 |
| Price/book (mrq) | 10.21 |
| Enterprise value/revenue | 9.69 |
| Enterprise value/EBITDA | 25.46 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.08 |
| 52-week change 3 | -3.30% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 325.00 |
| 52-week low 3 | 253.48 |
| 50-day moving average 3 | 287.92 |
| 200-day moving average 3 | 282.05 |
Share statistics
| Avg vol (3-month) 3 | 3.92M |
| Avg vol (10-day) 3 | 4.26M |
| Shares outstanding 5 | 1.21B |
| Implied shares outstanding 6 | 1.21B |
| Float 8 | 488.7M |
| % held by insiders 1 | 58.01% |
| % held by institutions 1 | 18.74% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 8.8 |
| Forward annual dividend yield 4 | 2.89% |
| Trailing annual dividend rate 3 | 5.80 |
| Trailing annual dividend yield 3 | 1.92% |
| 5-year average dividend yield 4 | 1.01 |
| Payout ratio 4 | 87.63% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 22 Nov 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 33.86% |
| Operating margin (ttm) | 35.95% |
Management effectiveness
| Return on assets (ttm) | 15.96% |
| Return on equity (ttm) | 34.23% |
Income statement
| Revenue (ttm) | 35.94B |
| Revenue per share (ttm) | 29.66 |
| Quarterly revenue growth (yoy) | 12.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 13.58B |
| Net income avi to common (ttm) | 12.17B |
| Diluted EPS (ttm) | 10.05 |
| Quarterly earnings growth (yoy) | 22.90% |
Balance sheet
| Total cash (mrq) | 21.19B |
| Total cash per share (mrq) | 17.51 |
| Total debt (mrq) | 181.98M |
| Total debt/equity (mrq) | 0.50% |
| Current ratio (mrq) | 2.69 |
| Book value per share (mrq) | 29.89 |
Cash flow statement
| Operating cash flow (ttm) | 12.59B |
| Levered free cash flow (ttm) | 6.01B |
© 2024 Yahoo. All rights reserved.